| For: | Wu AW, Gu J, Ji JF, Li ZF, Xu GW. Role of COX-2 in carcinogenesis of colorectal cancer and its relationship with tumor biological characteristics and patients’ prognosis. World J Gastroenterol 2003; 9(9): 1990-1994 [PMID: 12970891 DOI: 10.3748/wjg.v9.i9.1990] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v9/i9/1990.htm |
| Number | Citing Articles |
| 1 |
Ming Li, Yan-Hua Yuan, Yan Han, Yue-Xiang Liu, Li Yan, Yu Wang, Jin Gu. Expression Profile of Cancer-Testis Genes in 121 Human Colorectal Cancer Tissue and Adjacent Normal Tissue. Clinical Cancer Research 2005; 11(5) doi: 10.1158/1078-0432.CCR-04-1365
|
| 2 |
Mário Jucá, Benicio Luiz Bulhões Barros Paula Nunes, Hunaldo Lima de Menezes, Edmundo Guilherme de Almeida Gomes, Delcio Matos. Metaloproteinases 1 e 7 e câncer colorretal. Revista Brasileira de Coloproctologia 2008; 28(3) doi: 10.1590/S0101-98802008000300016
|
| 3 |
Xiao-Li Chen, Bao-Shan Su, Run-Qin Sun, Jun Zhang, Yi-Li Wang. Relationship between expression and distribution of cyclooxygenase-2 and bcl-2 in human gastric adenocarcinoma. World Journal of Gastroenterology 2005; 11(8): 1228-1231 doi: 10.3748/wjg.v11.i8.1228
|
| 4 |
Annika Gustafsson, Elisabeth Hansson, Ulf Kressner, Svante Nordgren, Marianne Andersson, Wenhua Wang, Christina Lönnroth, Kent Lundholm. EP1–4 subtype, COX and PPARγ receptor expression in colorectal cancer in prediction of disease‐specific mortality. International Journal of Cancer 2007; 121(2) doi: 10.1002/ijc.22582
|
| 5 |
M. Doré. Cyclooxygenase-2 Expression in Animal Cancers. Veterinary Pathology 2011; 48(1) doi: 10.1177/0300985810379434
|
| 6 |
Domenick J. Braccia, Glory Minabou Ndjite, Ashley Weiss, Sophia Levy, Stephenie Abeysinghe, Xiaofang Jiang, Mihai Pop, Brantley Hall. Gut Microbiome–Wide Search for Bacterial Azoreductases Reveals Potentially Uncharacterized Azoreductases Encoded in the Human Gut Microbiome. Drug Metabolism and Disposition 2023; 51(1) doi: 10.1124/dmd.122.000898
|
| 7 |
You Shang, Jiadi Du, Hong Cui. Synthesis of Celecoxib, its Pro-drugs and Radiolabeled Derivatives. A Brief Review. Organic Preparations and Procedures International 2014; 46(2) doi: 10.1080/00304948.2014.884371
|
| 8 |
Amir M. Salem, Mariem A. Elfeky, Nashwa Nawar, Ahmed Z. Alattar, Omar Atef Elekiabi, Mostafa M. Elaidy. Prognostic Value of Combined; Cox-2, Cyclin D1 and P21 Expression in Colorectal Cancer (CRC) Patients: An Immunohistochemical Study. Open Journal of Pathology 2018; 8(03) doi: 10.4236/ojpathology.2018.83013
|
| 9 |
GJ Dai. Anticancer effects of tea polyphenols on colorectal cancer with microsatellite instability in nude mice. Journal of Chinese Integrative Medicine 2008; 6(12) doi: 10.3736/jcim20081211
|
| 10 |
Exploration of Antioxidant, Anti-inflammatory and Anticancer Potential of Substituted 4-Thiazolidinone Derivatives: Synthesis, Biological Evaluation and Docking Studies. Polycyclic Aromatic Compounds 2023; 43(1) doi: 10.1080/10406638.2021.2019796
|
| 11 |
Sabha Rasool, Vamiq Rasool, Tahira Naqvi, Bashir A. Ganai, Bhahwal Ali Shah. Genetic unraveling of colorectal cancer. Tumor Biology 2014; 35(6) doi: 10.1007/s13277-014-1713-7
|
| 12 |
Firouzeh Biramijamal, Shaghayegh Basatvat, Arash Hossein-Nezhad, Maryam Sadat Soltani, Kambiz Akbari Noghabi, Guity Irvanloo, Kourosh Shamimi. Association of COX-2 Promoter Polymorphism with Gastrointestinal Tract Cancer in Iran. Biochemical Genetics 2010; 48(11-12) doi: 10.1007/s10528-010-9372-x
|
| 13 |
Amanda J. Boyle, Andrea Narvaez, Junchao Tong, Sami S. Zoghbi, Victor W. Pike, Robert B. Innis, Neil Vasdev. Repurposing [11C]MC1 for PET Imaging of Cyclooxygenase-2 in Colorectal Cancer Xenograft Mouse Models. Molecular Imaging and Biology 2022; 24(3) doi: 10.1007/s11307-021-01675-0
|
| 14 |
Ling Peng, Yun Zhou, Yina Wang, Haibo Mou, Qiong Zhao, Syed A. Aziz. Prognostic Significance of COX-2 Immunohistochemical Expression in Colorectal Cancer: A Meta-Analysis of the Literature. PLoS ONE 2013; 8(3) doi: 10.1371/journal.pone.0058891
|
| 15 |
Patrick A. Adegboyega, Omiyosoye Ololade, Jamal Saada, Randy Mifflin, John F. Di Mari, Don W. Powell. Subepithelial Myofibroblasts Express Cyclooxygenase-2 in Colorectal Tubular Adenomas. Clinical Cancer Research 2004; 10(17) doi: 10.1158/1078-0432.CCR-0431-03
|
| 16 |
Shuji Ogino, Gregory J. Kirkner, Katsuhiko Nosho, Natsumi Irahara, Shoko Kure, Kaori Shima, Aditi Hazra, Andrew T. Chan, Reiko Dehari, Edward L. Giovannucci, Charles S. Fuchs. Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer. Clinical Cancer Research 2008; 14(24) doi: 10.1158/1078-0432.CCR-08-1841
|
| 17 |
J.B. Tuynman, M.P. Peppelenbosch, D.J. Richel. COX-2 inhibition as a tool to treat and prevent colorectal cancer. Critical Reviews in Oncology/Hematology 2004; 52(2) doi: 10.1016/j.critrevonc.2004.08.004
|
| 18 |
K. Almendingen, A. T. Høstmark, L. N. Larsen, O. Fausa, J. Bratlie, L. Aabakken. Relationship between Fecal Content of Fatty Acids and Cyclooxygenase mRNA Expression and Fatty Acid Composition in Duodenal Biopsies, Serum Lipoproteins, and Dietary Fat in Colectomized Familial Adenomatous Polyposis Patients. Journal of Nutrition and Metabolism 2010; 2010 doi: 10.1155/2010/862569
|
| 19 |
Kari Almendingen, Laila N. Larsen, Olav Fausa, Jorunn Bratlie, Arne T. Høstmark, Lars Aabakken. Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP. Familial Cancer 2010; 9(4) doi: 10.1007/s10689-010-9365-2
|
| 20 |
Imen Miladi-Abdennadher, Rania Abdelmaksoud-Dammak, Dorra Ben Ayed-Guerfali, Lobna Ayadi, Abdelmajid Khabir, Ali Amouri, Foued Frikha, Nabil Tahri, Sameh Ellouz, Mounir Frikha, Tahia Sellami-Boudawara, Raja Mokdad-Gargouri. Expression of COX-2 and E-cadherin in Tunisian patients with colorectal adenocarcinoma. Acta Histochemica 2012; 114(6) doi: 10.1016/j.acthis.2011.11.002
|
| 21 |
Valeria Barresi, Maddalena Grosso, Enrica Vitarelli, Giovanni Tuccari, Gaetano Barresi. 5-Lipoxygenase is Coexpressed with Cox-2 in Sporadic Colorectal Cancer: A Correlation with Advanced Stage. Diseases of the Colon & Rectum 2007; 50(10) doi: 10.1007/s10350-007-0311-9
|
| 22 |
Labile Togba Soumaoro, Hiroyuki Uetake, Tetsuro Higuchi, Yoko Takagi, Masayuki Enomoto, Kenichi Sugihara. Cyclooxygenase-2 Expression. Clinical Cancer Research 2004; 10(24) doi: 10.1158/1078-0432.CCR-04-0653
|
| 23 |
A. TATSUGUCHI, T. KISHIDA, S. FUJIMORI, S. TANAKA, K. GUDIS, S. SHINJI, K. FURUKAWA, T. TAJIRI, Y. SUGISAKI, Y. FUKUDA, C. SAKAMOTO. Differential expression of cyclo‐oxygenase‐2 and nuclear β‐catenin in colorectal cancer tissue. Alimentary Pharmacology & Therapeutics 2006; 24(s4) doi: 10.1111/j.1365-2036.2006.00039.x
|
| 24 |
Francesco Mariani, Paola Sena, Laura Marzona, Massimo Riccio, Rita Fano, Paola Manni, Carmela Di Gregorio, Annalisa Pezzi, Maurizio Ponz de Leon, Sebastiano Monni, Anto De Pol, Luca Roncucci. Cyclooxygenase-2 and Hypoxia-Inducible Factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis. Cancer Letters 2009; 279(2) doi: 10.1016/j.canlet.2009.02.001
|
| 25 |
K Almendingen, A Brevik, D A Nymoen, H T Hilmarsen, P A Andresen, L F Andersen, M Vatn. Modulation of COX-2 expression in peripheral blood cells by increased intake of fruit and vegetables?. European Journal of Clinical Nutrition 2005; 59(4) doi: 10.1038/sj.ejcn.1602110
|
| 26 |
Annelies Debucquoy, Laurence Goethals, Louis Libbrecht, Christiaan Perneel, Karel Geboes, Nadine Ectors, William H. McBride, Karin Haustermans. Molecular and clinico-pathological markers in rectal cancer: a tissue micro-array study. International Journal of Colorectal Disease 2009; 24(2) doi: 10.1007/s00384-008-0608-8
|
| 27 |
Ashley E. Stewart, Martin H. Heslin, Jorge Arch, Nirag Jhala, Brian Ragland, Fernando Gomez, Kirby I. Bland, J. Pablo Arnoletti. Cyclooxygenase-2 Expression and Clinical Outcome in Gastrointestinal Stromal Tumors. Journal of Gastrointestinal Surgery 2006; 10(2) doi: 10.1016/j.gassur.2005.05.012
|
| 28 |
Robert Benamouzig, Bernard Uzzan, Antoine Martin, Jacques Deyra, Julian Little, Bernard Girard, Stanislas Chaussade. Cyclooxygenase-2 expression and recurrence of colorectal adenomas: effect of aspirin chemoprevention. Gut 2010; 59(5) doi: 10.1136/gut.2008.175406
|
| 29 |
Carina Pereira, Rui M. Medeiros, Mário J. Dinis-Ribeiro. Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?. European Journal of Gastroenterology & Hepatology 2009; 21(1) doi: 10.1097/MEG.0b013e32830ce7ba
|
| 30 |
Andriana Purnama, Kiki Lukman, Reno Rudiman, Dwi Prasetyo, Yoni Fuadah, Prapanca Nugraha, Valeska Siulinda Candrawinata. The prognostic value of COX-2 in predicting metastasis of patients with colorectal cancer: A systematic review and meta analysis. Heliyon 2023; 9(10) doi: 10.1016/j.heliyon.2023.e21051
|
| 31 |
Haonan Zhao, Xiaojie Zheng, Guo Lin, Xiaomin Wang, Huiyuan Lu, Pengpeng Xie, Siqi Jia, Yiyang Shang, Yan Wang, Pengchu Bai, Xuan Zhang, Ning Tang, Xingshun Qi. Effects of air pollution on the development and progression of digestive diseases: an umbrella review of systematic reviews and meta-analyses. BMC Public Health 2025; 25(1) doi: 10.1186/s12889-024-21257-3
|
| 32 |
A. TATSUGUCHI, T. KISHIDA, S. FUJIMORI, S. TANAKA, K. GUDIS, S. SHINJI, K. FURUKAWA, T. TAJIRI, Y. SUGISAKI, Y. FUKUDA, C. SAKAMOTO. Differential expression of cyclo‐oxygenase‐2 and nuclear β‐catenin in colorectal cancer tissue. Alimentary Pharmacology & Therapeutics Symposium Series 2006; 2(1) doi: 10.1111/j.1746-6342.2006.00039.x
|
| 33 |
Martin Philpott, Lynnette R Ferguson. Immunonutrition and cancer. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 2004; 551(1-2) doi: 10.1016/j.mrfmmm.2004.03.005
|
| 34 |
Abla Sayed Mahmoud, Ayesha Umair, Saleh Nasser Azzeghaiby, Fahad Hussain Alqahtani, Salah Hanouneh, Bassel Tarakji. Expression of Cyclooxygenase-2 (COX-2) in Colorectal Adenocarcinoma: an Immunohistochemical and Histopathological Study. Asian Pacific Journal of Cancer Prevention 2014; 15(16) doi: 10.7314/APJCP.2014.15.16.6787
|
| 35 |
Ketevan Pachkoria, Hong Zhang, Gunnar Adell, Ingvar Jarlsfelt, Xiao-Feng Sun. Significance of Cox-2 expression in rectal cancers with or without preoperative radiotherapy. International Journal of Radiation Oncology*Biology*Physics 2005; 63(3) doi: 10.1016/j.ijrobp.2005.02.031
|
| 36 |
Juan F. Marquez Ruiz, Kinga Kedziora, Brian Keogh, Jacqueline Maguire, Mary Reilly, Henry Windle, Dermot P. Kelleher, John F. Gilmer. A double prodrug system for colon targeting of benzenesulfonamide COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters 2011; 21(22) doi: 10.1016/j.bmcl.2011.09.071
|
| 37 |
Se Min Jang, Young Jin Jun, Woong Na, Si‐Hyong Jang, Kyueng Whan Min, Young Soo Song, Ki‐Seok Jang, Hong Xiu Han, Kang Hong Lee, Seung Sam Paik. Clinicopathologic significance of cyclooxygenase‐2 overexpression in colorectal adenocarcinoma. Basic and Applied Pathology 2010; 3(1) doi: 10.1111/j.1755-9294.2009.01064.x
|
| 38 |
Ni Shi, Kenneth M. Riedl, Steven J. Schwartz, Xiaoli Zhang, Steven K. Clinton, Tong Chen. Efficacy comparison of lyophilised black raspberries and combination of celecoxib and PBIT in prevention of carcinogen-induced oesophageal cancer in rats. Journal of Functional Foods 2016; 27 doi: 10.1016/j.jff.2016.08.044
|
| 39 |
Kristel C. Lobo Prabhu, Lan Vu, Simon K. Chan, Terry Phang, Allen Gown, Steven J. Jones, Sam M. Wiseman. Predictive utility of cyclo-oxygenase-2 expression by colon and rectal cancer. The American Journal of Surgery 2014; 207(5) doi: 10.1016/j.amjsurg.2013.12.019
|
| 40 |
Deniz Yamac, Gokhan Celenkoglu, Ugur Coskun, Nalan Akyurek, Zafer Akcali, Ayse Dursun, Fulya Koybasioglu. Prognostic importance of COX-2 expression in patients with colorectal cancer. Pathology - Research and Practice 2005; 201(7) doi: 10.1016/j.prp.2005.04.006
|
| 41 |
Anantha Krishna Chaitanya Divvela, Siva Reddy Challa, Israiel Kumar Tagaram. Pathogenic Role of Cyclooxygenase-2 in Cancer. JOURNAL OF HEALTH SCIENCE 2010; 56(5) doi: 10.1248/jhs.56.502
|
| 42 |
Janet K. Horton, Joel E. Tepper. Staging of Colorectal Cancer: Past, Present, and Future. Clinical Colorectal Cancer 2005; 4(5) doi: 10.3816/CCC.2005.n.002
|
| 43 |
M. Spychalski, L. Dziki, A. Dziki. Chemoprevention of colorectal cancer – a new target needed?. Colorectal Disease 2007; 9(5) doi: 10.1111/j.1463-1318.2006.01166.x
|
| 44 |
Christina Pfister, Rainer Ritz, Heike Pfrommer, Antje Bornemann, Marcos S. Tatagiba, Florian Roser. Are there attacking points in the eicosanoid cascade for chemotherapeutic options in benign meningiomas?. Neurosurgical FOCUS 2007; 23(4) doi: 10.3171/foc.2007.23.4.9
|
| 45 |
Andrew T. Kunzmann, Liam J. Murray, Chris R. Cardwell, Charlene M. McShane, Úna C. McMenamin, Marie M. Cantwell. PTGS2 (Cyclooxygenase-2) Expression and Survival among Colorectal Cancer Patients: A Systematic Review. Cancer Epidemiology, Biomarkers & Prevention 2013; 22(9) doi: 10.1158/1055-9965.EPI-13-0263
|
| 46 |
Benicio L.B.B.P. Nunes, Mário J. Jucá, Edmundo G.A. Gomes, Hunaldo L. Menezes, Henrique O. Costa, Delcio Matos, Sarhan S. Saad. Metalloproteinase-1, Metalloproteinase-7, and p53 Immunoexpression and their Correlation with Clinicopathological Prognostic Factors in Colorectal Adenocarcinoma. The International Journal of Biological Markers 2009; 24(3) doi: 10.1177/172460080902400305
|
| 47 |
Safiye Aktaş, Aydanur Kargı, Nur Olgun, Gulden Diniz, Ayşe Erbay, Canan Vergin. Prognostic significance of cyclooxygenase-2 expression in pediatric Hodgkin and non-Hodgkin lymphomas with or without Epstein–Barr virus latent infection. Comparative Clinical Pathology 2008; 17(2) doi: 10.1007/s00580-007-0710-2
|
| 48 |
William F Anderson, Asad Umar, Ernest T Hawk. Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opinion on Pharmacotherapy 2003; 4(12) doi: 10.1517/14656566.4.12.2193
|
| 49 |
Hongfei Guo, Atsushi Tatsuguchi, Seiichi Shinji, Shunji Fujimori, Shu Tanaka, Katya Gudis, Yuichi Sugisaki, Kiyonori Furukawa, Takashi Tajiri, Yuh Fukuda, Teruyuki Kishida, Choitsu Sakamoto. Cyclooxygenase-2 Expression Correlates With Membrane-Type-1 Matrix Metalloproteinase Expression in Colorectal Cancer Tissue. Diseases of the Colon & Rectum 2006; 49(8) doi: 10.1007/s10350-006-0588-0
|
| 50 |
KYRIAKOS ZAFIRELLIS, GEORGE AGROGIANNIS, AGLAIA ZACHAKI. Prognostic value of COX‐2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer . APMIS 2008; 116(10) doi: 10.1111/j.1600-0463.2008.01104.x
|
| 51 |
Amani Kazem, Khaled El Sayed, Yasser El Kerm. Prognostic significance of COX-2 and β-catenin in colorectal carcinoma. Alexandria Journal of Medicine 2014; 50(3) doi: 10.1016/j.ajme.2013.05.007
|
| 52 |
Mostafa M. El‐Serafi, Abeer A. Bahnassy, Nasr M. Ali, Salem M. Eid, Mahmoud M. Kamel, Nayera A. Abdel‐Hamid, Abdel‐Rahman N. Zekri. The prognostic value of c‐Kit, K‐ras codon 12, and p53 codon 72 mutations in Egyptian patients with stage II colorectal cancer. Cancer 2010; 116(21) doi: 10.1002/cncr.25417
|
| 53 |
Robert Benamouzig, Bernard Uzzan, Jacques Deyra, Antoine Martin, Bernard Girard, Julian Little, Stanislas Chaussade. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial. Gut 2012; 61(2) doi: 10.1136/gutjnl-2011-300113
|
| 54 |
Pamela New. Cyclooxygenase in the Treatment of Glioma: Its Complex Role in Signal Transduction. Cancer Control 2004; 11(3) doi: 10.1177/107327480401100303
|
| 55 |
YAN-YAN LONG, YU WANG, QIAN-RONG HUANG, GUANG-SHUN ZHENG, SHUN-CHANG JIAO. Measurement of serum antibodies against NY-ESO-1 by ELISA: A guide for the treatment of specific immunotherapy for patients with advanced colorectal cancer. Experimental and Therapeutic Medicine 2014; 8(4) doi: 10.3892/etm.2014.1913
|
| 56 |
Guang-Wei Xu, Jia-Fu Ji, Zhen-Fu Li, Jin Gu, Ai-Wen Wu. COX-2 expression and tumor angiogenesis in colorectal cancer. World Journal of Gastroenterology 2004; 10(16): 2323-2326 doi: 10.3748/wjg.v10.i16.2323
|